Daniel Teper

Daniel Gedeon Teper is the founder of Novagali Pharma SA, founded in 1999.
Dr. Teper was the founder of Immune Pharmaceuticals, Inc., founded in 2010, and served as Director from 2017 to 2018.
Dr. Teper is the founder of Cytovia Therapeutics, Inc., founded in 2019, and serves as Chairman since 2023.
Dr. Teper is also the founder of Vector Therapeutics, Inc.,Wintech Pharmaceuticals..
Dr. Teper is President, Chief Executive Officer & Director at Cytovia, Inc. (Massachusetts).
Dr. Teper is Chief Executive Officer & Director at NAYA Therapeutics, Inc. Dr. Teper is Chief Executive Officer & Director at Cytovia, Inc. Dr. Teper is Chairman, Chief Executive & Financial Officer at Oxygen Therapy, Inc. since 2018.
Dr. Teper is Member-Supervisory Board at Crossject SA since 2023.
Dr. Teper is Managing Partner at AA & Sons since 2025.
Dr. Teper was Vice Chairman at Phoenix BioPharm, Inc. Dr. Teper was President & Director at INVO Fertility, Inc. from 2024 to 2025.
Dr. Teper was Managing Director at Bionest Partners LLC.
Dr. Teper was Global President at Havas Life Paris SA from 1996 to 1999.
Dr. Teper was Senior Vice President-Business Development at SoftWatch, Inc. Dr. Teper was Senior Vice President & Head-Marketing & Sales at GlaxoSmithKline LLC from 1990 to 1992.
Dr. Teper was Partner at Iso Healthcare Consulting.
Dr. Teper was President & Chief Operating Officer at Laboratoires Delagrange.
Dr. Teper earned a doctorate from Université Paris-Saclay in 1983.
Dr. Teper earned an MBA from INSEAD in 1984.